Arecor Ltd - Unquoted

Arecor was a spin-out from Insense (qv) to commercialise technology developed by Insense for enabling biologics to maintain their integrity without the need for refrigeration - this both reduces cost and also helps deployment in developing countries where temperature monitored cold storage facilities are in short supply. The technology also assists in maintaining the integrity and function of proteins exposed to ionizing radiation as the means of sterilisation.

 

Links:
Arecor

Last Updated: 24/07/2018

Investment Information:
date of first inv: Jan 2008
cost: £141,000
valn at: 30/06/2018 £252,000
equity held: 1.9%